The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
γ-Secretase inhibitors and modulators
Open accessAbstract
γ-Secretase is a fascinating, multi-subunit, intramembrane-cleaving protease that is now being considered as a therapeutic target for a number of diseases. Potent, orally bioavailable γ-secretase inhibitors (GSIs) have been developed and tested in humans with Alzheimer's disease (AD) and cancer. Preclinical studies also suggest the therapeutic potential for GSIs in other disease conditions. However, due to inherent mechanism based-toxicity of non-selective inhibition of γ-secretase, clinical development of GSIs will require empirical testing with careful evaluation of benefit versus risk. In addition to GSIs, compounds referred to as γ-secretase modulators (GSMs) remain in development as AD therapeutics. GSMs do not inhibit γ-secretase, but modulate γ-secretase processivity and thereby shift the profile of the secreted amyloid β peptides (Aβ) peptides produced. Although GSMs are thought to have an inherently safe mechanism of action, their effects on substrates other than the amyloid β protein precursor (APP) have not been extensively investigated. Herein, we will review the current state of development of GSIs and GSMs and explore pertinent biological and pharmacological questions pertaining to the use of these agents for select indications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis
Zhang, P., Yang, Y., Zweidler‐McKay, P. A., & Hughes, D. P. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1992 · Cited by 163
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. S., Schroeter, E. H., Schrijvers, V., Wolfe, M. S., Ray, W. J., et al. (1999) · Nature · doi:10.1038/19083 · Cited by 2,100
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationWolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., & Selkoe, D. J. (1999) · Nature · doi:10.1038/19077 · Cited by 1,916
Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain
Schroeter, E. H., Kisslinger, J. A., & Kopan, R. (1998) · Nature · doi:10.1038/30756 · Cited by 1,624
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,465
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Self-citationA subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Self-citationJack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex
De Strooper, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00205-8 · Cited by 965
Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain
Dovey, H. F., John, V., Anderson, J. P., Chen, L. Z., De Saint Andrieu, P., Fang, L. Y., Freedman, S. B., Folmer, B., Goldbach, E., Holsztynska, E. J., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00012.x · Cited by 875
The role of presenilin cofactors in the γ-secretase complex
Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y., Thinakaran, G., & Iwatsubo, T. (2003) · Nature · doi:10.1038/nature01506 · Cited by 867
Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
Li, Y.-M., Xu, M., Lai, M.-T., Huang, Q., Castro, J. L., DiMuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J. G., et al. (2000) · Nature · doi:10.1038/35015085 · Cited by 866
The secretases: enzymes with therapeutic potential in Alzheimer disease
De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799
Self-citationN OTCH AND P RESENILIN: Regulated Intramembrane Proteolysis Links Development and Degeneration
Selkoe, D., & Kopan, R. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131334 · Cited by 636
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634
Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice
McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.030 · Cited by 565
Self-citationγ-Secretase: proteasome of the membrane?
Kopan, R., & Ilagan, M. X. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1406 · Cited by 554
Kuperstein, I., Broersen, K., Benilova, I., Rozenski, J., Jonckheere, W., Debulpaep, M., Vandersteen, A., Segers‐Nolten, I., Van Der Werf, K., Subramaniam, V., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.211 · Cited by 532
Identification of Signal Peptide Peptidase, a Presenilin-Type Aspartic Protease
Weihofen, A., Binns, K., Lemberg, M. K., Ashman, K., & Martoglio, B. (2002) · Science · doi:10.1126/science.1070925 · Cited by 532
Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state
Li, Y.-M., Lai, M.-T., Xu, M., Huang, Q., DiMuzio-Mower, J., Sardana, M. K., Shi, X.-P., Yin, K.-C., Shafer, J. A., & Gardell, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110126897 · Cited by 525
Takami, M., Nagashima, Y., Sano, Y., Ishihara, S., Morishima-Kawashima, M., Funamoto, S., & Ihara, Y. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2362-09.2009 · Cited by 498
The mechanism of γ‐Secretase dysfunction in familial Alzheimer disease
Chávez‐Gutiérrez, L., Bammens, L., Benilova, I., Vandersteen, A., Benurwar, M., Borgers, M., Lismont, S., Zhou, L., Van Cleynenbreugel, S., Esselmann, H., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.79 · Cited by 495
The Many Substrates of Presenilin/γ-Secretase
Haapasalo, A., & Kovacs, D. M. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101065 · Cited by 458
The nervous system and innate immunity: the neuropeptide connection
Brogden, K. A., Guthmiller, J. M., Salzet, M., & Zasloff, M. (2005) · Nature Immunology · doi:10.1038/ni1209 · Cited by 446
γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
Real, P. J., Tosello, V., Palomero, T., Castillo, M., Hernando, E., de Stanchina, E., Sulis, M. L., Barnes, K., Sawai, C., Homminga, I., et al. (2009) · Nature Medicine · doi:10.1038/nm.1900 · Cited by 445
Iijima, K., Liu, H.-P., Chiang, A.-S., Hearn, S. A., Konsolaki, M., & Zhong, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400895101 · Cited by 440
The Notch pathway in podocytes plays a role in the development of glomerular disease
Niranjan, T., Bielesz, B., Gruenwald, A., Ponda, M. P., Kopp, J. B., Thomas, D. B., & Susztak, K. (2008) · Nature Medicine · doi:10.1038/nm1731 · Cited by 427
Association of γ-Secretase with Lipid Rafts in Post-Golgi and Endosome Membranes
Vetrivel, K. S., Cheng, H., Lin, W., Sakurai, T., Li, T., Nukina, N., Wong, P. C., Xu, H., & Thinakaran, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407986200 · Cited by 413
Mizutari, K., Fujioka, M., Hosoya, M., Bramhall, N., Okano, H. J., Okano, H., & Edge, A. S. B. (2013) · Neuron · doi:10.1016/j.neuron.2012.10.032 · Cited by 399
Rational targeting of Notch signaling in cancer
Rizzo, P., Osipo, C., Foreman, K., Golde, T., Osborne, B., & Miele, L. (2008) · Oncogene · doi:10.1038/onc.2008.226 · Cited by 395
Self-citationHerzig, M. C., Winkler, D. T., Burgermeister, P., Pfeifer, M., Kohler, E., Schmidt, S. D., Danner, S., Abramowski, D., Stürchler-Pierrat, C., Bürki, K., et al. (2004) · Nature Neuroscience · doi:10.1038/nn1302 · Cited by 391
Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer
Rodilla, V., Villanueva, A., Obrador-Hevia, A., Robert-Moreno, À., Fernández-Majada, V., Grilli, A., López-Bigas, N., Bellora, N., Albà, M. M., Torres, F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813221106 · Cited by 384
Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Golde, T. E., Schneider, L. S., & Koo, E. H. (2011) · Neuron · doi:10.1016/j.neuron.2011.01.002 · Cited by 382
Self-citationCoric, V., van Dyck, C. H., Salloway, S., Andreasen, N., Brody, M., Richter, R. W., Soininen, H., Thein, S., Shiovitz, T., Pilcher, G., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.2194 · Cited by 374
Aβ40 Inhibits Amyloid Deposition In Vivo
Kim, J., Onstead, L., Randle, S., Price, R., Smithson, L., Zwizinski, C., Dickson, D. W., Golde, T., & McGowan, E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4849-06.2007 · Cited by 359
Self-citationCholesterol-Dependent γ-Secretase Activity in Buoyant Cholesterol-Rich Membrane Microdomains
Wahrle, S., Das, P., Nyborg, A. C., McLendon, C., Shoji, M., Kawarabayashi, T., Younkin, L. H., Younkin, S. G., & Golde, T. E. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0470 · Cited by 356
Self-citationBielesz, B., Sirin, Y., Si, H., Niranjan, T., Gruenwald, A., Ahn, S., Kato, H., Pullman, J., Gessler, M., Haase, V. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43025 · Cited by 345
Intramembrane Proteolysis: Theme and Variations
Wolfe, M. S., & Kopan, R. (2004) · Science · doi:10.1126/science.1096187 · Cited by 332
A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous system
Bateman, R. J., Siemers, E. R., Mawuenyega, K. G., Wen, G., Browning, K. R., Sigurdson, W. C., Yarasheski, K. E., Friedrich, S. W., DeMattos, R. B., May, P. C., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21623 · Cited by 322
Presenilin-1 and -2 Are Molecular Targets for γ-Secretase Inhibitors
Seiffert, D., Bradley, J. D., Rominger, C. M., Rominger, D. H., Yang, F., Meredith, J. E., Wang, Q., Roach, A. H., Thompson, L. A., Spitz, S. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005430200 · Cited by 301
The Profile of Soluble Amyloid β Protein in Cultured Cell Media
Wang, R., Sweeney, D., Gandy, S. E., & Sisodia, S. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31894 · Cited by 294
Notch as a Mediator of Cell Fate Determination in Hematopoiesis: Evidence and Speculation
Milner, L. A., & Bigas, A. (1999) · Blood · doi:10.1182/blood.v93.8.2431 · Cited by 293
Gu, Y., Misonou, H., Sato, T., Dohmae, N., Takio, K., & Ihara, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100357200 · Cited by 292
Citron, M., Diehl, T. S., Gordon, G., Biere, A. L., Seubert, P., & Selkoe, D. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13170 · Cited by 288
Age-Dependent Neurodegeneration and Alzheimer-Amyloid Plaque Formation in Transgenic Drosophila
Greeve, I., Kretzschmar, D., Tschäpe, J.-A., Beyn, A., Brellinger, C., Schweizer, M., Nitsch, R. M., & Reifegerste, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0283-04.2004 · Cited by 287
Meng, R. D., Shelton, C. C., Li, Y.-M., Qin, L.-X., Notterman, D., Paty, P. B., & Schwartz, G. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2088 · Cited by 287
Diverse compounds mimic Alzheimer disease–causing mutations by augmenting Aβ42 production
Kukar, T., Murphy, M. P., Eriksen, J. L., Sagi, S. A., Weggen, S., Smith, T. E., Ladd, T., Khan, M. A., Kache, R., Beard, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1235 · Cited by 284
Self-citationThe role of Aβ42 in Alzheimer's disease
Younkin, S. G. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80035-1 · Cited by 282
Minter, L. M., Turley, D. M., Das, P., Shin, H. M., Joshi, I., Lawlor, R. G., Cho, O. H., Palaga, T., Gottipati, S., Telfer, J. C., et al. (2005) · PubMed · Cited by 281
Self-citationSubstrate-targeting γ-secretase modulators
Kukar, T. L., Ladd, T. B., Bann, M. A., Fraering, P. C., Narlawar, R., Maharvi, G. M., Healy, B., Chapman, R., Welzel, A. T., Price, R. W., et al. (2008) · Nature · doi:10.1038/nature07055 · Cited by 280
Self-citationWeggen, S., Eriksen, J. L., Sagi, S. A., Pietrzik, C. U., Ozols, V., Fauq, A., Golde, T. E., & Koo, E. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303592200 · Cited by 280
Self-citationPreclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
Schott, A. F., Landis, M. D., Dontu, G., Griffith, K. A., Layman, R. M., Krop, I., Paskett, L. A., Wong, H., Dobrolecki, L. E., Lewis, M. T., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3326 · Cited by 277
Aster, J. C., Pear, W. S., & Blacklow, S. C. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154300 · Cited by 266
γ-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer’s Disease
Serneels, L., Van Biervliet, J., Craessaerts, K., Dejaegere, T., Horré, K., Van Houtvin, T., Esselmann, H., Paul, S., Schäfer, M. K., Berezovska, O., et al. (2009) · Science · doi:10.1126/science.1171176 · Cited by 260
Role of Notch and its oncogenic signaling crosstalk in breast cancer
Guo, S., Liu, M., & Gonzalez-Perez, R. R. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.12.002 · Cited by 260
Kounnas, M. Z., Danks, A. M., Cheng, S., Tyree, C., Ackerman, E., Zhang, X., Ahn, K., Nguyen, P., Comer, D., Mao, L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.018 · Cited by 252
Arumugam, T. V., Chan, S. L., Jo, D.-G., Yilmaz, G., Tang, S.-C., Cheng, A., Gleichmann, M., Okun, E., Dixit, V. D., Chigurupati, S., et al. (2006) · Nature Medicine · doi:10.1038/nm1403 · Cited by 247
Self-citationAmyloid precursor protein secretases as therapeutic targets for traumatic brain injury
Loane, D. J., Pocivavsek, A., Moussa, C. E.-H., Thompson, R., Matsuoka, Y., Faden, A. I., Rebeck, G. W., & Burns, M. P. (2009) · Nature Medicine · doi:10.1038/nm.1940 · Cited by 246
Golde, T. E., Eckman, C. B., & Younkin, S. G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00043-0 · Cited by 244
Self-citationNovel Research Horizons for Presenilins and γ-Secretases in Cell Biology and Disease
De Strooper, B., & Annaert, W. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100109-104117 · Cited by 234
Lichtenthaler, S. F., Wang, R., Grimm, H., Uljon, S. N., Masters, C. L., & Beyreuther, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3053 · Cited by 234
Presenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1
Okochi, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf541 · Cited by 229
Spatial Segregation of γ-Secretase and Substrates in DistinctMembraneDomains
Vetrivel, K. S., Cheng, H., Kim, S.-H., Chen, Y., Barnes, N. Y., Parent, A. T., Sisodia, S. S., & Thinakaran, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503570200 · Cited by 221
Maillard, I., Adler, S. H., & Pear, W. S. (2003) · Immunity · doi:10.1016/s1074-7613(03)00325-x · Cited by 219
A Substrate-Based Difluoro Ketone Selectively Inhibits Alzheimer's γ-Secretase Activity
Wolfe, M. S., Citron, M., Diehl, T. S., Xia, W., Donkor, I. O., & Selkoe, D. J. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970621b · Cited by 215
NOTCH Signaling as a Novel Cancer Therapeutic Target
Miele, L., Miao, H., & Nickoloff, B. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777441771 · Cited by 201
Self-citationHassan, K. A., Wang, L., Korkaya, H., Chen, G., Maillard, I., Beer, D. G., Kalemkerian, G. P., & Wicha, M. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0370 · Cited by 199
Wei, P., Walls, M., Qiu, M., Ding, R., Denlinger, R. H., Wong, A., Tsaparikos, K., Jani, J. P., Hosea, N., Sands, M., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0034 · Cited by 195
Luistro, L., He, W., Smith, M., Packman, K., Vilenchik, M., Carvajal, D., Roberts, J., Cai, J., Berkofsky-Fessler, W., Hilton, H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1843 · Cited by 191
Mullendore, M. E., Koorstra, J.-B., Li, Y.-M., Offerhaus, G. J., Fan, X., Henderson, C. M., Matsui, W., Eberhart, C. G., Maitra, A., & Feldmann, G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2004 · Cited by 188
Structure of a presenilin family intramembrane aspartate protease
Li, X., Dang, S., Yan, C., Gong, X., Wang, J., & Shi, Y. (2013) · Nature · doi:10.1038/nature11801 · Cited by 186
Identification of a novel family of presenilin homologues
Ponting, C. P. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1037 · Cited by 174
Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease
van Es, J. H., & Clevers, H. C. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.09.008 · Cited by 173
Notch signaling contributes to the pathogenesis of human osteosarcomas
Engin, F., Bertin, T., Ma, O., Jiang, M. M., Wang, L., Sutton, R. E., Donehower, L. A., & Lee, B. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp057 · Cited by 168
Complex interplay between -catenin signalling and Notch effectors in intestinal tumorigenesis
Peignon, G., Durand, A., Cacheux, W., Ayrault, O., Terris, B., Laurent‐Puig, P., Shroyer, N. F., SEUNINGEN, I. V., Honjo, T., Perret, C., et al. (2011) · Gut · doi:10.1136/gut.2009.204719 · Cited by 167
Page, R. M., Baumann, K., Tomioka, M., Pérez-Revuelta, B. I., Fukumori, A., Jacobsen, H., Flohr, A., Luebbers, T., Ozmen, L., Steiner, H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708754200 · Cited by 165
Alzheimer's failure raises questions about disease-modifying strategies
Extance, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3288 · Cited by 165
Barten, D. M., Guss, V. L., Corsa, J. A., Loo, A., Hansel, S. B., Zheng, M., Munoz, B., Srinivasan, K., Wang, B., Robertson, B. J., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075408 · Cited by 159
Self-citationBlocking the NOTCH Pathway Inhibits Vascular Inflammation in Large-Vessel Vasculitis
Piggott, K., Deng, J., Warrington, K. J., Younge, B. R., Kubo, J. T., Desai, M., Goronzy, J. J., & Weyand, C. M. (2011) · Circulation · doi:10.1161/circulationaha.110.936203 · Cited by 159
Murphy, M. P., Hickman, L., Eckman, C. B., Uljon, S., Wang, R., & Golde, T. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11914 · Cited by 159
Self-citationNotch Inhibition as a Promising New Approach to Cancer Therapy
Purow, B. W. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_23 · Cited by 158
Siemers, E., Dean, R. A., Friedrich, S. W., Ferguson‐Sells, L. R., Gonzales, C., Farlow, M. R., & May, P. C. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31805b7660 · Cited by 154
Osborne, B. A., & Miele, L. (1999) · Immunity · doi:10.1016/s1074-7613(00)80140-5 · Cited by 150
Self-citationInhibition and Modulation of γ-Secretase for Alzheimer's Disease
Wolfe, M. S. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.010 · Cited by 146
A γ-secretase-like intramembrane cleavage of TNFα by the GxGD aspartyl protease SPPL2b
Fluhrer, R., Grammer, G., Israel, L., Condron, M. M., Haffner, C., Friedmann, E., Böhland, C., Imhof, A., Martoglio, B., Teplow, D. B., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1450 · Cited by 140
Pinnix, I., Musunuru, U., Tun, H. W., Sridharan, A., Golde, T. E., Eckman, C. B., Ziani‐Cherif, C., Onstead, L., & Sambamurti, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005968200 · Cited by 140
Self-citationYabuuchi, S., Pai, S. G., Campbell, N. R., de Wilde, R. F., Oliveira, E. D., Korangath, P. C., Streppel, M. M., Rasheed, Z. A., Hidalgo, M. M., Maitra, A., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.054 · Cited by 140
Guo, S., & Gonzalez-Perez, R. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021467 · Cited by 139
Wakabayashi, T., Craessaerts, K., Bammens, L., Bentahir, M., Borgions, F., Herdewijn, P., Staes, A., Timmerman, E., Vandekerckhove, J., Rubinstein, E., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1978 · Cited by 135
Weggen, S., Eriksen, J. L., Sagi, S. A., Pietrzik, C. U., Golde, T. E., & Koo, E. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304824200 · Cited by 129
Self-citationKukar, T. L., Prescott, S., Eriksen, J. L., Holloway, V. M., Murphy, M. P., Koo, E. H., Golde, T. E., & Nicolle, M. M. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-54 · Cited by 128
Self-citationJagged-1 and Notch3 Juxtacrine Loop Regulates Ovarian Tumor Growth and Adhesion
Choi, J., Park, J. T., Davidson, B., Morin, P. J., Shih, I., & Wang, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0001 · Cited by 128
Lin, C., Wang, F., Hsu, Y.-C., Chen, C., Tseng, M., Saleem, M. A., Chang, P., & Wang, J. (2010) · Diabetes · doi:10.2337/db09-0663 · Cited by 126
Schneppenheim, J., Dressel, R., Hüttl, S., Lüllmann‐Rauch, R., Engelke, M., Dittmann, K., Wienands, J., Eskelinen, E., Hermans‐Borgmeyer, I., Fluhrer, R., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121069 · Cited by 125
Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains
Moore, B. D., Chakrabarty, P., Levites, Y., Kukar, T. L., Baine, A.-M. T., Moroni, T., Ladd, T. B., Das, P., Dickson, D. W., & Golde, T. E. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt121 · Cited by 116
Self-citationMolecular Dependence of Estrogen Receptor–Negative Breast Cancer on a Notch-Survivin Signaling Axis
Lee, C. W., Raskett, C. M., Prudovsky, I. A., & Altieri, D. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6673 · Cited by 115
Phenylpiperidine‐type γ‐secretase modulators target the transmembrane domain 1 of presenilin 1
Ohki, Y., Higo, T., Uemura, K., Shimada, N., Osawa, S., Berezovska, O., Yokoshima, S., Fukuyama, T., Tomita, T., & Iwatsubo, T. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.372 · Cited by 113
Mayer, S. C., Kreft, A. F., Harrison, B. L., Abou-Gharbia, M. A., Antane, M. M., Aschmies, S., Atchison, K. P., Chlenov, M. A., Cole, D. C., Comery, T. A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801252w · Cited by 111
Processing of Notch and amyloid precursor protein by γ-secretase is spatially distinct
Tarassishin, L., Yin, Y. I., Bassit, B., & Li, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408007101 · Cited by 111
Pozdnyakov, N., Murrey, H. E., Crump, C. J., Pettersson, M., Ballard, T. E., Ende, C. W. A., Ahn, K., Li, Y., Bales, K. R., & Johnson, D. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.398602 · Cited by 109
Richter, L., Munter, L. M., Neß, J., Hildebrand, P. W., Dasari, M., Unterreitmeier, S., Bulic, B., Beyermann, M., Gust, R., Reif, B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003026107 · Cited by 106
A Sensitive and Quantitative Assay for Measuring Cleavage of Presenilin Substrates
Karlström, H., Bergman, A., Lendahl, U., Näslund, J., & Lundkvist, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100649200 · Cited by 103
Active γ‐secretase is localized to detergent‐resistant membranes in human brain
Hur, J., Welander, H., Behbahani, H., Aoki, M., Frånberg, J., Winblad, B. G., Frykman, S., & Tjernberg, L. O. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06278.x · Cited by 101
Presenilin 1 Regulates Pharmacologically Distinct γ-Secretase Activities
Murphy, M. P., Uljon, S., Fraser, P. E., Fauq, A. H., Lookingbill, H. A., Findlay, K. A., Smith, T. E., Lewis, P. A., McLendon, D. C., Wang, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002812200 · Cited by 101
Self-citationWhat the halted phase III γ‐secretase inhibitor trial may (or may not) be telling us
Schor, N. F. (2011) · Annals of Neurology · doi:10.1002/ana.22365 · Cited by 101
Pear, W. S., & Aster, J. C. (2004) · Current Opinion in Hematology · doi:10.1097/01.moh.0000143965.90813.70 · Cited by 100
Gasparini, L., Rusconi, L., Xu, H., Soldato, P. D., & Ongini, E. (2003) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02154.x · Cited by 98
Li, T., Wen, H., Brayton, C. F., Das, P., Smithson, L. A., Fauq, A. H., Fan, X., Crain, B. J., Price, D. L., Golde, T. E., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703649200 · Cited by 96
Self-citationBMS-708,163 Targets Presenilin and Lacks Notch-Sparing Activity
Crump, C. J., Castro, S. V., Wang, F., Pozdnyakov, N., Ballard, T. E., Sisodia, S. S., Bales, K. R., Johnson, D. S., & Li, Y. (2012) · Biochemistry · doi:10.1021/bi301137h · Cited by 95
Martoglio, B., & Golde, T. E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg303 · Cited by 94
Self-citationBeisner, D. R., Langerak, P., Parker, A. E., Dahlberg, C. M., Otero, F. J., Sutton, S., Poirot, L., Barnes, W., Young, M. A., Niessen, S., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121072 · Cited by 92
Bergmann, H., Yabas, M., Short, A., Miosge, L. A., Barthel, N., Teh, C. E., Roots, C. M., Bull, K. R., Jeelall, Y. S., Horikawa, K., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121076 · Cited by 91
Targeting Aβ and tau in Alzheimer's disease, an early interim report
Golde, T. E., Petrucelli, L., & Lewis, J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.035 · Cited by 89
Self-citationAbramowski, D., Wiederhold, K.-H., Furrer, U., Jaton, A.-L., Neuenschwander, A., Runser, M.-J., Danner, S., Reichwald, J., Ammaturo, D., Staab, D., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.140327 · Cited by 89
Wang, R., Tang, P., Wang, P., Boissy, R. E., & Zheng, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509822102 · Cited by 88
Mutations in the Transmembrane Domain of APP Altering γ-Secretase Specificity
Lichtenthaler, S. F., Ida, N., Multhaup, G., Masters, C. L., & Beyreuther, K. T. (1997) · Biochemistry · doi:10.1021/bi971071m · Cited by 86
γ-Secretase as a Target for Alzheimer’s Disease
Wolfe, M. S. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00004-0 · Cited by 86
Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy
Gu, J.-W., Rizzo, P., Pannuti, A., Golde, T. E., Osborne, B. A., & Miele, L. (2012) · Vascular Cell · doi:10.1186/2045-824x-4-7 · Cited by 85
Self-citationImbimbo, B. P., Giudice, E. D., Colavito, D., D’Arrigo, A., Carbonare, M. D., Villetti, G., Facchinetti, F., Volta, R., Pietrini, V., Baroc, M. F., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.129007 · Cited by 84
Nyborg, A. C., Kornilova, A. Y., Jansen, K. R., Ladd, T. B., Wolfe, M. S., & Golde, T. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309305200 · Cited by 84
Self-citationRahimi, N., Golde, T. E., & Meyer, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2905 · Cited by 82
Self-citationVetrivel, K. S., Gong, P., Bowen, J. W., Cheng, H., Chen, Y., Carter, M., Nguyen, P. D., Placanica, L., Wieland, F., Li, Y., et al. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-4 · Cited by 79
Roderick, J. E., González‐Pérez, G., Kuksin, C. A., Dongre, A., Roberts, E. R., Srinivasan, J., Andrzejewski, C., Fauq, A. H., Golde, T. E., Miele, L., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20112615 · Cited by 78
Self-citationWild-type Presenilin 1 Protects against Alzheimer Disease Mutation-induced Amyloid Pathology
Wang, R., Wang, B., He, W., & Zheng, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512574200 · Cited by 75
Rogers, K., Felsenstein, K. M., Hrdlicka, L., Tu, Z., Albayya, F., Lee, W., Hopp, S., Miller, M.-J., Spaulding, D., Yang, Z., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-61 · Cited by 75
Self-citationIndependent Generation of Aβ42 and Aβ38 Peptide Species by γ-Secretase
Czirr, E., Cottrell, B. A., Leuchtenberger, S., Kukar, T. L., Ladd, T. B., Esselmann, H., Paul, S., Schubenel, R., Torpey, J. W., Pietrzik, C. U., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802912200 · Cited by 74
Self-citationNOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications
Clementz, A. G., Rogowski, A., Pandya, K., Miele, L., & Osipo, C. (2011) · Breast Cancer Research · doi:10.1186/bcr2900 · Cited by 74
Self-citationAblonczy, Z., Prakasam, A., Fant, J., Fauq, A. H., Crosson, C. E., & Sambamurti, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032391 · Cited by 72
García-Alloza, M., Subramanian, M., Thyssen, D. H., Borrelli, L. A., Fauq, A. H., Das, P., Golde, T. E., Hyman, B. T., & Bacskai, B. J. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-19 · Cited by 71
Self-citationPharmacodynamics of Selective Inhibition of γ-Secretase by Avagacestat
Albright, C. F., Dockens, R. C., Meredith, J. E., Olson, R. E., Slemmon, R., Lentz, K. A., Wang, J.-S., Denton, R., Pilcher, G. D., Rhyne, P., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.199356 · Cited by 67
Aster, J. C., & Pear, W. S. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200107000-00010 · Cited by 67
Sivilia, S., Lorenzini, L., Giuliani, A., Gusciglio, M., Fernández, M., Baldassarro, V. A., Mangano, C., Ferraro, L., Pietrini, V., Baroc, M. F., et al. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-44 · Cited by 66
Cummings, J. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.020 · Cited by 65
Piperidine Acetic Acid Based γ-Secretase Modulators Directly Bind to Presenilin-1
Crump, C. J., Fish, B. A., Castro, S. V., Chau, D.-M., Gertsik, N., Ahn, K., Stiff, C. M., Pozdnyakov, N., Bales, K. R., Johnson, D. S., et al. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200098p · Cited by 65
Vo, K. D., Amarasinghe, B., Washington, K. M., González, A., Berlin, J. D., & Dang, T. P. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-138 · Cited by 64
Portelius, E., Broeck, B. V., Andréasson, U., Gustavsson, M. K., Mercken, M. H., Zetterberg, H., Borghys, H., & Blennow, K. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100573 · Cited by 63
Kukar, T. L., Ladd, T. B., Robertson, P., Pintchovski, S. A., Moore, B. D., Bann, M. A., Ren, Z., Jansen‐West, K. R., Malphrus, K., Eggert, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274696 · Cited by 63
Self-citationDesign and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators
Bischoff, F., Berthelot, D., Cleyn, M. A. J. D., Macdonald, G. J., Minne, G., Oehlrich, D., Pieters, S., Surkyn, M., Trabanco, A. A., Tresadern, G., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201710f · Cited by 63
Identification of γ-Secretase Inhibitor Potency Determinants on Presenilin
Zhao, B., Yu, M., Neitzel, M. L., Marugg, J. L., Jagodzinski, J. J., Lee, M., Hu, K., Schenk, D., Yednock, T. A., & Basi, G. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708870200 · Cited by 61
Wang, M., Wu, L., Wang, L. Q., & Xin, X. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.103 · Cited by 60
Broeck, B. V., Chen, J., Tréton, G., Desmidt, M., Hopf, C., Ramsden, N. G., Karran, E. H., Mercken, M. H., & Rowley, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01207.x · Cited by 59
Huang, R., Zhou, Q., Veeraragoo, P., Yu, H., & Xiao, Z. (2011) · Renal Failure · doi:10.3109/0886022x.2011.553979 · Cited by 59
Czirr, E., Leuchtenberger, S., Dorner‐Ciossek, C., Schneider, A., Jucker, M., Koo, E. H., Pietrzik, C. U., Baumann, K., & Weggen, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700618200 · Cited by 54
Self-citationAmyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease
Basi, G. S., Hemphill, S. S., Brigham, E. F., Liao, A., Aubele, D. L., Baker, J., Barbour, R., Bova, M. P., Chen, X., Dappen, M. S., et al. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt60 · Cited by 53
Nyborg, A. C., Jansen, K. R., Ladd, T. B., Fauq, A. H., & Golde, T. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405879200 · Cited by 53
Self-citationSun, Z. J., Asberom, T., Bara, T. A., Bennett, C. E., Burnett, D. A., Chu, I., Clader, J. W., Cohen-Williams, M. E., Cole, D., Czarniecki, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201407j · Cited by 53
He, W., Luistro, L. L., Carvajal, D. M., Smith, M., Nevins, T., Yin, X., Cai, J. J., Higgins, B., Kolinsky, K. D., Rizzo, C., et al. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.01.001 · Cited by 51
Piperidine-derived γ-secretase modulators
Hall, A., Elliott, R. L., Giblin, G. M. P., Hussain, I., Musgrave, J., Naylor, A., Sasse, R. Z., & Smith, B. B. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.072 · Cited by 51
The lymphovascular embolus of inflammatory breast cancer exhibits a Notch 3 addiction
Xiao, Y. Q., Ye, Y.-S., Zou, X., Jones, S., Yearsley, K. H., Shetuni, B., Tellez, J. D., & Barsky, S. H. (2010) · Oncogene · doi:10.1038/onc.2010.405 · Cited by 49
Wang, H., Luo, W., Zhang, Y., Li, Y., Thinakaran, G., Greengard, P., & Xu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404345200 · Cited by 46
Optimization of a Natural Product-Based Class of γ-Secretase Modulators
Hubbs, J. L., Fuller, N. O., Austin, W., Shen, R., Creaser, S. P., McKee, T. D., Loureiro, R. M. B., Tate, B. A., Xia, W., Ives, J. L., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300976b · Cited by 46
Borgegård, T., Gustavsson, S., Nilsson, C. B., Parpal, S., Klintenberg, R., Berg, A., Rosqvist, S., Serneels, L., Svensson, S., Olsson, F., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1451-12.2012 · Cited by 44
Targett‐Adams, P., Schaller, T., Hope, G., Lanford, R. E., Lemon, S. M., Martin, A., & McLauchlan, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605373200 · Cited by 44
In vitro and in vivo profiling of CHF5022 and CHF5074
Imbimbo, B. P., Giudice, E. D., Cenacchi, V., Volta, R., Villetti, G., Facchinetti, F., Riccardi, B., Puccini, P., Moretto, N., Grassi, F., et al. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2006.12.010 · Cited by 43
Foamy Virus Envelope Protein Is a Substrate for Signal Peptide Peptidase-like 3 (SPPL3)
Voß, M., Fukumori, A., Kuhn, P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371369 · Cited by 43
Higaki, J. N., Chakravarty, S., Bryant, C. M., Cowart, L. R., Harden, P., Scardina, J. M., Mavunkel, B. J., Luedtke, G. R., & Cordell, B. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990009f · Cited by 42
Piperazinyl pyrimidine derivatives as potent γ-secretase modulators
Rivkin, A., Ahearn, S. P., Chichetti, S. M., Kim, Y. R., Li, C., Rosenau, A., Kattar, S. D., Jung, J. O., Shah, S., Hughes, B. L., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.101 · Cited by 42
Watters, J., Cheng, C., Majumder, P. K., Wang, R., Yalavarthi, S., Meeske, C., Kong, L., Sun, W., Lin, J., Heyer, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1544 · Cited by 40
Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects
Imbimbo, B. P., Frigerio, E., Breda, M., Fiorentini, F., Fernández, M., Sivilia, S., Giardino, L., Calzà, L., Norris, D., Casula, D., et al. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3182622ace · Cited by 37
Purine derivatives as potent γ-secretase modulators
Rivkin, A., Ahearn, S. P., Chichetti, S. M., Hamblett, C. L., Garcia, Y., Martinez, M., Hubbs, J. L., Reutershan, M. H., Daniels, M. H., Siliphaivanh, P., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.008 · Cited by 37
Physiologic and Pathologic Events Mediated by Intramembranous and Juxtamembranous Proteolysis
Golde, T. E., & Eckman, C. B. (2003) · Science Signaling · doi:10.1126/stke.2003.172.re4 · Cited by 36
Self-citationDas, P., Verbeeck, C., Minter, L. M., Chakrabarty, P., Felsenstein, K. M., Kukar, T. L., Maharvi, G. M., Fauq, A. H., Osborne, B. A., & Golde, T. E. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-39 · Cited by 36
Self-citationLee, J., Song, L., Terracina, G., Bara, T. A., Josien, H. B., Asberom, T., Sasikumar, T., Burnett, D. A., Clader, J. W., Parker, E. M., et al. (2011) · Biochemistry · doi:10.1021/bi200026m · Cited by 35
Sagi, S. A., Lessard, C. B., Winden, K. D., Maruyama, H., Koo, J. C., Weggen, S., Kukar, T. L., Golde, T. E., & Koo, E. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277228 · Cited by 33
Self-citationTong, G., Castaneda, L., Wang, J.-S., Sverdlov, O., Huang, S., Slemmon, R., Gu, H., Wong, O. T., Li, H., Berman, R., et al. (2012) · Clinical Drug Investigation · doi:10.1007/s40261-012-0006-4 · Cited by 33
Higaki, J. N., Murphy, G. M., & Cordell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010333.x · Cited by 33
Parvanova, I., Epiphânio, S., Fauq, A. H., Golde, T. E., Prudêncio, M., & Mota, M. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005078 · Cited by 32
Self-citationFluorinated piperidine acetic acids as γ-secretase modulators
Stanton, M. G., Hubbs, J. L., Sloman, D. L., Hamblett, C. L., Andrade, P. B., Angagaw, M. H., Bi, G., Black, R. M., Crispino, J. L., Cruz, J. C., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.034 · Cited by 31
Signal Peptide Peptidase and γ-Secretase Share Equivalent Inhibitor Binding Pharmacology
Iben, L. G., Olson, R. E., Balanda, L. A., Jayachandra, S., Robertson, B., Hay, V., Corradi, J., Prasad, C. V. C., Zaczek, R. C., Albright, C. F., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707002200 · Cited by 27
Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators
Qin, J., Dhondi, P., Huang, X., Mandal, M., Zhao, Z., Pissarnitski, D. A., Zhou, W. J., Aslanian, R. G., Zhu, Z., Greenlee, W. J., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.012 · Cited by 27
N-Substituted carbazolyloxyacetic acids modulate Alzheimer associated γ-secretase
Narlawar, R., Pérez‐Revuelta, B. I., Baumann, K., Schubenel, R., Haass, C., Steiner, H., & Schmidt, B. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.061 · Cited by 25
-Secretase Modulators: Can We Combine Potency with Safety?
Gijsen, H. J. M., & Mercken, M. H. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/295207 · Cited by 25
NerveCenter: Phase III Alzheimer trial halted: Search for therapeutic biomarkers continues
Samson, K. (2010) · Annals of Neurology · doi:10.1002/ana.22249 · Cited by 25
Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models
Loureiro, R. M. B., Dumin, J. A., McKee, T. D., Austin, W., Fuller, N. O., Hubbs, J. L., Shen, R., Jonker, J., Ives, J. L., Bronk, B. S., et al. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt173 · Cited by 24
Aminothiazoles as γ-secretase modulators
Lübbers, T., Flohr, A., Jolidon, S., David‐Pierson, P., Jacobsen, H., Ozmen, L., & Baumann, K. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.060 · Cited by 22
Xin, Z., Peng, H., Zhang, A. J., Talreja, T., Kumaravel, G., Xu, L. S., Rohde, E., Jung, M.-Y., Shackett, M. N., Kocisko, D. A., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.047 · Cited by 20
Characterization of an Atypical γ-Secretase Complex from Hematopoietic Origin
Placanica, L., Chien, J. W., & Li, Y. (2010) · Biochemistry · doi:10.1021/bi901388t · Cited by 20
Ye, X. M., Konradi, A. W., Smith, J. L., Aubele, D. L., Garofalo, A. W., Marugg, J. L., Neitzel, M. L., Semko, C. M., Sham, H. L., Sun, M., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.148 · Cited by 20
Ye, X. M., Konradi, A. W., Smith, J. L., Xu, Y., Dressen, D. B., Garofalo, A. W., Marugg, J. L., Sham, H. L., Truong, A. P., Jagodzinski, J. J., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.039 · Cited by 18
The Pathogenesis of Alzheimer's Disease and the Role of Aβ42
Golde, T. E. (2007) · CNS Spectrums · doi:10.1017/s1092852900025876 · Cited by 17
Self-citationThe Intramembrane Protease SPPL2A Is Critical for Tooth Enamel Formation
Bronckers, A. L. J. J., Gueneli, N., Lüllmann‐Rauch, R., Schneppenheim, J., Moraru, A. P., Himmerkus, N., Bervoets, T. J. M., Fluhrer, R., Everts, V. E., Säftig, P., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1895 · Cited by 16
Samson, K. (2010) · Annals of Neurology · doi:10.1002/ana.22048 · Cited by 14
Therapeutic effect of CHF5074, a new γ-secretase modulator, in a mouse model of scrapie
Poli, G., Corda, E., Lucchini, B., Puricelli, M., Martino, P. A., Dall’Ara, P., Villetti, G., Bareggi, S. R., Corona, C., Costassa, E. V., et al. (2012) · Prion · doi:10.4161/pri.6.1.18317 · Cited by 13
Kurosumi, M., Nishio, Y., Osawa, S., Kobayashi, H., Iwatsubo, T., Tomita, T., & Miyachi, H. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.131 · Cited by 7
An Empirical Model of γ‐Secretase Activity
MURPHY, M. P., Wang, R., Fraser, P. E., Fauq, A. H., & Golde, T. E. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06928.x · Cited by 4
Self-citation
Cited by
Notch signaling pathway: architecture, disease, and therapeutics
Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00934-y · Cited by 1,114
Notch Signaling in Development, Tissue Homeostasis, and Disease
Siebel, C., & Lendahl, U. (2017) · Physiological Reviews · doi:10.1152/physrev.00005.2017 · Cited by 978
Therapeutic strategies for Alzheimer's disease in clinical trials
Godyń, J., Jończyk, J., Panek, D., & Malawska, B. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2015.07.006 · Cited by 452
Targeting protein aggregation for the treatment of degenerative diseases
Eisele, Y. S., Monteiro, C., Fearns, C., Encalada, S. E., Wiseman, R. L., Powers, E. T., & Kelly, J. W. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4593 · Cited by 419
The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
Ricciarelli, R., & Fedele, E. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170116143743 · Cited by 380
Metadata
- Authors
- Golde, T. E., Koo, E. H., Felsenstein, K. M., Osborne, B. A., & Miele, L.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 1828
- Issue
- 12
- Pages
- 2898-2907
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2178572083
- Cited by
- 272
- References
- 193
- FWCI
- 16.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.